Upadacitinib for the Treatment of Recalcitrant Vulvar Lichen Sclerosus

Upadacitinib may be an effective treatment option for recalcitrant vulvar LS. More robust studies are needed to fully evaluate the efficacy and limitations of JAK inhibitors in treating lichen sclerosus.

Authors

Margaret Cocks (ORCID: https://orcid.org/0000-0002-3409-0871)
Jamie W. Rhoads
Courtney M. Kenyon

Institutions

University of Utah (US)

Publication Details

Journal: Journal of Lower Genital Tract Disease
Published: 2026-03-02
DOI: https://doi.org/10.1097/lgt.0000000000000941
Primary Topic: Genital Health and Disease
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Upadacitinib for the Treatment of Recalcitrant Vulvar Lichen Sclerosus

Margaret Cocks, Jamie W. Rhoads, Courtney M. Kenyon

Mar 2, 2026

Journal of Lower Genital Tract Disease

Genital Health and Disease

article

Upadacitinib for the Treatment of Recalcitrant Vulvar Lichen Sclerosus

Margaret Cocks, Jamie W. Rhoads, Courtney M. Kenyon

March 2, 2026article en

Abstract

Journal of Lower Genital Tract Disease

University of Utah (US)

Openalex Percentile: Top 37%

Genital Health and Disease

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Upadacitinib for the Treatment of Recalcitrant Vulvar Lichen Sclerosus — Margaret Cocks, Jamie W. Rhoads, et al. · Journal of Lower Genital Tract Disease (2026) | TGRS Research Map | TGRS